Phase 2 trials
Scope
Date
~
-
Earnings
Korean e-commerce Coupang logs profits in Q3-Q4 2022
South Korean e-commerce giant Coupang Inc. achieved record-high yearly revenue and operating profits for two consecutive quarters between July to De...
Mar 01, 2023 (Gmt+09:00)
-
Pension funds
S.Korea's GEPS logs 10.2% return on alternative assets in 2022
South Korea’s Government Employees Pension Service (GEPS) had a 4.4% loss on investment last year, seeing its assets under management (AUM) dr...
Mar 01, 2023 (Gmt+09:00)
-
IPOs
Battery material maker EcoPro Materials eyes $2.3 billion IPO
EcoPro Materials Co., a unit of South Korea’s battery materials group EcoPro Group, is looking to list its shares on the country’s main ...
Feb 28, 2023 (Gmt+09:00)
-
Batteries
Korea’s L&F in $2.9 billion deal to supply battery material to Tesla
South Korea’s leading battery materials maker L&F Co. said on Tuesday it has signed a $2.91 billion deal to supply cathode, a key electric...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials
Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...
Feb 28, 2023 (Gmt+09:00)
-
Carbon neutrality
SK Ecoplant's Singaporean affiliate, Thailand's No. 2 conglomerate to develop green power
Singapore's TES, an electronic waste management specialist and subsidiary of South Korea's SK Ecoplant Co., will jointly pursue the development of e...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Jetema applies to test its botulinum toxin in US from July
South Korea's bio-esthetic pharmaceutical company Jetema Co. will hold clinical trials in the US to advance to the American market, the world's bigg...
Feb 27, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
EQT Partners to acquire S.Korea’s SK Shieldus for $2.3 bn
EQT Partners AB, the world’s third-largest private equity firm, is poised to buy a controlling stake in South Korean security service provider...
Feb 26, 2023 (Gmt+09:00)
-
Batteries
Korean firms scurry to expand nickel, lithium supply chains
South Korea’s leading companies such as SK, POSCO, LG and LX are scurrying to expand their supply chains for lithium and nickel, key raw mater...
Feb 24, 2023 (Gmt+09:00)
-
Bio & Pharma
US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle
Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...
Feb 24, 2023 (Gmt+09:00)
-
Future mobility
Daewoo E&C, Jeju Air kick off K-UAM Grand Challenge phase 1 project
Daewoo Engineering & Construction Co. and Jeju Air Co. have teamed up to participate in the Korean urban air mobility (K-UAM) project. The two c...
Feb 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Foreign exchange
S.Korean won near 2-month low as US data fans Fed hike views
The South Korean won skidded to a near two-month low on Friday as hotter-than-forecast US inflation data added to expectations that the Federal Rese...
Feb 17, 2023 (Gmt+09:00)
-
Economy
S.Korea's Engel coefficient rises sharply amid COVID-19 pandemic
South Korea’s low-income households are feeling the pinch of rising food prices amid the COVID-19 pandemic, according to a report by a local t...
Feb 17, 2023 (Gmt+09:00)
-
Logistics
S.Korea's Kakao Enterprise introduces Matching 2.0 strategy
Kakao Enterprise, a leading IT platform business operator in South Korea, recently announced its "Matching 2.0" strategy to enhance the quality of s...
Feb 17, 2023 (Gmt+09:00)
-
Korean stock market
Samsung C&T to cancel $2.3 bn worth of treasury shares, stocks up
Samsung C&T Corp.’s share price zoomed on Thursday on news that the company will cancel its entire treasury stock holdings worth about 2.9...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
POSCO Int'l's pharmaceutical biz in Sudan attains No. 2 market ranking
A pharmaceutical company in Sudan set up by South Korea's POSCO International to find business opportunities in and make social contributions to the...
Feb 16, 2023 (Gmt+09:00)
-
Aerospace & Defense
KAI expects 2023 sales to grow by a third, driven by fighter jets
Korea Aerospace Industries Ltd. (KAI), South Korea’s sole military aircraft manufacturer, said on Wednesday it aims to achieve 3.83 trillion w...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem builds S.Korea's first plant for clinical trials
LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...
Feb 14, 2023 (Gmt+09:00)
-
Corporate bonds
SK Hynix set for largest-ever corporate bond issue at bargain prices
SK Hynix Inc., the world’s second-largest memory chipmaker, is gearing up for its largest-ever corporate bond issue in South Korea at lower-th...
Feb 08, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom to launch multimodal AI to match ChatGPT
South Korea’s SK Telecom Co. will adopt natural language generation and processing capabilities for its nascent artificial intelligence servic...
Feb 08, 2023 (Gmt+09:00)
-
Batteries
Korea EV battery makers lose market share against Chinese rivals
South Korean electric vehicle cell makers lost a market share against Chinese competitors last year as they failed to fully benefit from a surge in ...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus
Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...
Feb 08, 2023 (Gmt+09:00)
-
Earnings
Fintech firm Kakao Pay logs first yearly net profit in 2022
Kakao Pay Corp., the mobile payment service unit of South Korean tech giant Kakao Corp., posted a net profit last year for the first time since its ...
Feb 08, 2023 (Gmt+09:00)
-
Sovereign bonds
S.Korean institutional investors inject more capital in MMFs
South Korean institutional investors, such as pension funds, mutual aids and corporates, are rushing to money market funds (MMFs) for short-term pro...
Feb 06, 2023 (Gmt+09:00)
-
ESG
LG Group to invest $2.7 bn in decarbonization by 2030
South Korea's No. 4 conglomerate LG Corp. is set to accelerate its net zero by 2050 strategies.LG will invest 3.4 trillion won ($2.7 billion) by 203...
Feb 05, 2023 (Gmt+09:00)
-
Earnings
LG Uplus narrows operating profit gap with bigger rivals in 2022
LG Uplus Corp., South Korea’s third-largest mobile carrier, reported more than 1 trillion won ($814.2 million) in operating profit in 2022 for...
Feb 03, 2023 (Gmt+09:00)
-
Korean stock market
Korea Shipbuilding & Offshore Engineering ends fears over stock overhang
Korea Shipbuilding & Offshore Engineering (KSOE), a subholding company for shipbuilding, oil refining and machinery conglomerate HD Hyundai Co. ...
Feb 03, 2023 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet